P025: RADAR: An international phase III, PET response‐adapted, randomised trial in progress, comparing ABVD±ISRT with brentuximab vedotin+AVD±ISRT in patients with previously untreated limited‐stage classical Hodgkin lymphoma

Radford J, Adedayo T, Ardavan A, Barrington SF, Berkahn L, Chauvie S, Clifton‐Hadley L, Collins GP, Crump M, Cutter D, Edwards D, Hutchings M
,
et al
No abstract available
Keywords:

32 Biomedical and Clinical Sciences

,

3201 Cardiovascular Medicine and Haematology

,

3211 Oncology and Carcinogenesis

,

Rare Diseases

,

Hodgkin's Disease

,

Lymphatic Research

,

Hematology

,

Cancer

,

Lymphoma

,

6.1 Pharmaceuticals

,

Cancer